iBio, Inc., a leader in the plant-made pharmaceutical field, today announced that the U.S. Patent and Trademark Office has issued a patent that covers the viral vectors comprising the iBioLaunch™ platform. iBio owns this proprietary…
Today, BluePhoenix Solutions announced the execution of a definitive agreement to sell its AppBuilder business to Magic Software Enterprise Ltd (NASDAQ: MGIC) for $17 million. Magic Software provides mobile and cloud-enabled application and business integration…
Ventrus Biosciences Inc., a NY-based pharmaceutical developer, while still development stage, has assembled a strong portfolio of product candidates targeting the late-stage prescription market, specifically in the gastrointestinal disorder area. A massive, underserved market of…
Uranium Energy is pleased to announce that, effective on October 25, 2011, the Company has entered into a Property Purchase Agreement (the “Purchase Agreement”) with three Paraguayan companies (collectively, the “Vendors”) pursuant to which the…
Threshold Pharmaceuticals Inc., a biotech company focused on building a pipeline of drugs superior to conventional anticancer drugs, recently announced its ongoing phase III clinical trial results for its clinical stage hypoxia-activated prodrug, TH-302, which…
Wizzard Media, the world’s largest podcast network, today announced that is has begun a private beta version test of its OnPublish program which will integrate support for both Facebook and Twitter in the libsyn.com publishing…
Lake Shore Gold Corp. (LSG), a Company that engages in the acquisition, exploration, and development of gold properties in northern Ontario and Quebec of Canada, as well as in Mexico, has reported the results of…
USA Technologies, Inc., a leader of wireless, cashless payment and M2M telemetry solutions for self-serve, small ticket retailing industries, today announced positive earnings for the first fiscal quarter which reflected a record 25 million small…
SciClone Pharmaceuticals is a China-centric specialty pharmaceutical company focused on therapies for oncology and infectious diseases, along with cardiovascular, urological, respiratory, and central nervous system disorders. The company was founded in 1989 and is headquartered…
Dynavax Technologies Corp., a clinical-stage biopharmaceutical company that discovers and develops novel products to prevent and treat infectious and inflammatory diseases, today announced that it has unblinded its phase 3 primary endpoint immunogenicity data in…
Lighting Science Group released news today that in the past year, it has received more than $100 million of LED lighting product orders, representing more than a 100% increase compared to the numbers from last…
As any needle-phobic patient can tell you, a big part of medicine involves getting past the skin barrier. It’s an issue for getting medicine in, or getting blood out, and it’s more than a painful…
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, today announced its results for the third quarter ended September 30, 2011. The company…
PositiveID Corp., a company that develops medical devices and biological detection systems, focusing primarily on diabetes management, rapid medical testing, and airborne bio-threat detection, has developed the iglucose™ system to bring the future technology of…
Uranium Energy is pleased to announce the completion of its first uranium sale which will be reflected in the Company’s upcoming Fiscal 2012 Q1 report. A total of 60,000 pounds of U3O8 were sold for…
Cereplast, Inc. designs and manufactures proprietary bio-based, sustainable plastics which are used as substitutes for traditional plastics at a price that is competitive. The company offers products which meet a variety of customer needs. The…
AdCare Health Systems, Inc., a leading nursing home and assisted living provider, will hold a conference call on Wednesday, November 9, 2011 at 5:00 p.m. Eastern time to discuss results for the third quarter ended…
Accuray Inc., the premier radiation oncology company that develops, manufactures and sells personalized innovative treatment solutions, today announced that the U.S. Food and Drug Administration has granted the company 510(k) clearance for the marketing of…
MicroVision Inc., a leading provider of innovative ultra-miniature projection display technology, today announced its operating and financial results for the second quarter of 2011. For the three months ended June 30, 2011, MicroVision reported revenue…
Sharps Compliance Corp. is a leading full service provider of cost-effective management solutions for medical waste and unused dispensed medications generated outside the hospital and large health care facility setting. The company’s strategy is to…